Novo Nordisk
NVO
86.50
-17.73%
Novo Nordisk A/S engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark
Yahoo Finance
Download Now to Buy Novo Nordisk
Price Changes
-18.07%
1 Month
-32.41%
3 Months
-16.05%
1 Year
Specs
Min Quantity
0.01 Shares
Price Quotation
USD
Leverage
1:50
Market Cap
$482.15B
EPS (TTM)
$2.98
P/E Ratio (TTM)
34.71
NVT Ratio
9,024.73
Dividend Yield
1.40%
Beta (5Y, Monthly)
0.17
Trading Hours (GMT)
Saturday
00:00 - 01:00
Sunday
No Trading
Monday
01:00 - 00:00
Tuesday
00:00 - 18:00
Wednesday
No Trading
Thursday
09:00 - 00:00
Friday
00:00 - 00:00
Analyst Rating
Strong Sell [1]
Sell [1]
Hold [2]
Buy [2]
Strong Buy [5]
80.4
Target Price
3.8182
Average Score
The information presented above is for informational purposes only. It should not be interpreted as a recommendation to perform actions and/or investment advice and/or any type of consultation. You may review our KID documents here
